Catalyst Event
Tempus AI Inc (TEM) · Other
From Akros U.S. AI Software TOP4 Plus Index (AUAIS4P)
6/1/2026, 12:00:00 AM
Tempus announced the upcoming clinical availability of its first whole-genome sequencing assay, xH, for hematologic malignancies.
Korean Translation
Tempus, 혈액암에 대한 최초의 전체 게놈 시퀀싱 분석법인 xH의 임상적 이용 가능성을 발표함.
Related Recent Events
Tempus AI Inc (TEM) · Earnings Release
Tempus AI is scheduled to report its Q2 2026 financial results; earnings releases typically result in price moves of 5% or more, scheduled.
8/14/2026, 12:00:00 AM
AppLovin Corporation (APP) · Earnings Release
AppLovin's Q2 2026 earnings release is expected around August 5, 2026, based on past reporting schedules expected. Low impact estimated as the announcement of a date typically precedes the actual market-moving results.
8/5/2026, 12:00:00 AM
Oracle Corp (ORCL) · Earnings Release
Oracle is scheduled to release its fourth quarter and full fiscal year 2026 financial results after the market close on June 10, 2026, with a conference call to follow. High importance is estimated as earnings releases typically result in significant price volatility, scheduled.
6/10/2026, 12:00:00 AM
Innodata Inc (INOD) · Other
Annual Shareholder Meeting on 2026-06-04 scheduled.
6/4/2026, 12:00:00 AM
Snowflake Inc (SNOW) · Other
Stock price fell 8% on June 2, 2026, following new product and partnership announcements at the company's annual Snowflake Summit event.
6/2/2026, 12:00:00 AM
Fastly Inc (FSLY) · Other
Fastly management is scheduled to participate in a presentation at the William Blair 46th Annual Growth Stock Conference; low impact is estimated as conference presentations typically provide incremental updates scheduled.
6/2/2026, 12:00:00 AM